Cogent Biosciences (COGT) Interest & Investment Income (2017 - 2026)

Cogent Biosciences' Interest & Investment Income history runs 10 years deep, the most recent figure standing at $7.6 million for Q1 2026.

• In Q1 2026, Interest & Investment Income rose 157.72% year-over-year to $7.6 million; the TTM figure through Mar 2026 stood at $19.3 million (up 13.91% YoY), while the FY2025 annual figure was $14.7 million, down 18.79% from the prior year.
• Interest & Investment Income was $7.6 million for Q1 2026 at Cogent Biosciences, up from $5.5 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $7.6 million in Q1 2026 to a low of $107000.0 in Q1 2022.
• Historically, Interest & Investment Income has averaged $3.4 million across 5 years, with a median of $3.9 million in 2024.
• The sharpest annual moves came in 2023 and 2025: Interest & Investment Income surged 2019.63% in 2023, then slumped 56.0% in 2025.
• A 5-year view of Interest & Investment Income shows it stood at $2.1 million in 2022, then surged by 83.41% to $3.9 million in 2023, then retreated by 0.28% to $3.9 million in 2024, then surged by 41.93% to $5.5 million in 2025, then soared by 38.91% to $7.6 million in 2026.
• The last three Interest & Investment Income figures came in at $7.6 million (Q1 2026), $5.5 million (Q4 2025), and $3.9 million (Q3 2025), per Business Quant data.